THE PROGNOSTIC VALUE OF THE BIRMINGHAM VASCULITIS ACTIVITY SCORE AND THE VASCULITIS DAMAGE INDEX IN ANCA-ASSOCIATED VASCULITIS

THE PROGNOSTIC VALUE OF THE BIRMINGHAM VASCULITIS ACTIVITY SCORE AND THE VASCULITIS DAMAGE INDEX IN ANCA-ASSOCIATED VASCULITIS

Detalles Bibliográficos
Main Authors:	Suppiah, R, Batra, R, Robson, J, Arden, N, Flossmann, O, Harper, L, Hoglund, P, Jayne, D, Judge, A, Mukhtyar, C, Westman, K, Luqmani, R
Formato:	Conference item
Publicado:	2011

Títulos similares

Using the Birmingham vasculitis activity score (BVAS) to screen for vasculitis
por: Mukhtyar, C, et al.
Publicado: (2008)

Cardiovascular outcomes in ANCA associated vasculitis
por: Mukhtyar, C, et al.
Publicado: (2008)

A cross-sectional study of the Birmingham Vasculitis Activity Score version 3 in systemic vasculitis.
por: Suppiah, R, et al.
Publicado: (2011)

TREATMENT-RELATED DAMAGE IN THE ANCA-ASSOCIATED VASCULITIDES: AN ANALYSIS OF THE EUROPEAN VASCULITIS STUDY GROUP THERAPEUTIC TRIALS
por: Robson, J, et al.
Publicado: (2013)

Using the Birmingham Vasculitis Activity Score (BVAS) for diagnosing vasculitis
por: Luqmani, R, et al.
Publicado: (2009)

USING THE BIRMINGHAM VASCULITIS ACTIVITY SCORE (VERSION 3) FOR DIAGNOSING VASCULITIS
por: Mukhtyar, C, et al.
Publicado: (2009)

Long-term survival of ANCA-associated vasculitis
por: Flossmann, O, et al.
Publicado: (2009)

FACTORS ASSOCIATED WITH LONG-TERM DAMAGE IN THE ANCA-ASSOCIATED VASCULITIDES: AN ANALYSIS OF COHORTS FROM THE EUROPEAN VASCULITIS STUDY GROUP THERAPEUTIC TRIALS
por: Robson, J, et al.
Publicado: (2013)

Peripheral neuropathy in ANCA-associated vasculitis: outcomes from the European Vasculitis Study Group trials.
por: Suppiah, R, et al.
Publicado: (2011)

Damage in the anca-associated vasculitides: long-term data from the European Vasculitis Study group (EUVAS) therapeutic trials.
por: Robson, J, et al.
Publicado: (2015)

Damage in the ANCA-associated vasculitides: Long-term data from the European Vasculitis Study Group (EUVAS) therapeutic trials
por: Robson, J, et al.
Publicado: (2015)

Outcome measures in ANCA-associated vasculitis.
por: Suppiah, R, et al.
Publicado: (2010)

Peripheral neuropathy in ANCA-associated vasculitis: outcomes from the European Vasculitis Study Group trials
por: Suppiah, R, et al.
Publicado: (2011)

Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis.
por: Luqmani, R, et al.
Publicado: (1994)

Long-term patient survival in ANCA-associated vasculitis
por: Flossmann, O, et al.
Publicado: (2011)

Long-term patient survival in ANCA-associated vasculitis.
por: Flossmann, O, et al.
Publicado: (2011)

Modification and validation of the Birmingham Vasculitis Activity Score (version 3).
por: Mukhtyar, C, et al.
Publicado: (2009)

THE DEMOGRAPHY OF ANCA ASSOCIATED VASCULITIS: 735 PATIENTS RECRUITED AT DIAGNOSIS TO SIX EUROPEAN VASCULITIS STUDY GROUP TRIALS
por: Yew, S, et al.
Publicado: (2012)

Validation of the Birmingham Vasculitis Activity Score (Version 3)
por: Mukhtyar, C, et al.
Publicado: (2009)

Long-term patient survival in ANCA-associated vasculitis.
por: Flossmann, O, et al.
Publicado: (2011)

Damage assessment in ANCA-associated vasculitis.
por: Bhamra, K, et al.
Publicado: (2012)

THE DISEASE CHARACTERISTICS OF ANCA ASSOCIATED VASCULITIS: 735 PATIENTS RECRUITED AT DIAGNOSIS TO SIX EUROPEAN VASCULITIS STUDY GROUP TRIALS
por: Yew, S, et al.
Publicado: (2012)

Measurement of damage in systemic vasculitis: A comparison of the Vasculitis Damage Index with the Combined Damage Assessment Index
por: Suppiah, R, et al.
Publicado: (2010)

Using the Birmingham Vasculitis Activity Score as a Screening Tool in Patients with Suspected Vasculitis
por: Floris, A, et al.
Publicado: (2016)

Explaining fatigue in ANCA-associated vasculitis.
por: Basu, N, et al.
Publicado: (2013)

Explaining fatigue in ANCA-associated vasculitis
por: Basu, N, et al.
Publicado: (2013)

Markers for work disability in ANCA-associated vasculitis
por: Basu, N, et al.
Publicado: (2013)

The role of biologic therapies in the management of systemic vasculitis.
por: Chan, A, et al.
Publicado: (2006)

Measurement of damage in systemic vasculitis: a comparison of the Vasculitis Damage Index with the Combined Damage Assessment Index.
por: Suppiah, R, et al.
Publicado: (2011)

Diagnosis and management of ANCA associated vasculitis.
por: Berden, A, et al.
Publicado: (2012)

EULAR recommendations for conducting clinical studies and/or clinical trials in ANCA-associated vasculitis
por: Luqmani, R, et al.
Publicado: (2007)

OP0055 Using the Birmingham Vasculitis Activity Score as a screening tool in patients with suspected vasculitis
por: Floris, A, et al.
Publicado: (2016)

Birmingham Vasculitis Activity Score (BVAS) for use in European multi-centre clinical trials
por: Luqmani, R, et al.
Publicado: (2001)

Remission in antineutrophil cytoplasmic antibody-associated systemic vasculitis.
por: Mukhtyar, C, et al.
Publicado: (2006)

Maintenance of clinical remission in ANCA-associated vasculitis.
por: Luqmani, R
Publicado: (2013)

MEASUREMENT OF DAMAGE IN SYSTEMIC VASCULITIS: A COMPARISON OF THE VASCULITIS DAMAGE INDEX (VDI) WITH THE COMBINED DAMAGE ASSESSMENT INDEX (CDA)
por: Suppiah, R, et al.
Publicado: (2010)

Clinical Characteristics, Predictors for Mortality and Comparison of the Birmingham Vasculitis Activity Score and the Five-Factor Score on Survival in ANCA-Associated Vasculitis in Hong Kong
por: Joshua Ka Ho Yeung, et al.
Publicado: (2024-07-01)

CONTEXTUALISING QUALITY OF LIFE IN ANCA ASSOCIATED VASCULITIS (AAV)
por: Basu, N, et al.
Publicado: (2012)

The characterisation and determinants of quality of life in ANCA associated vasculitis.
por: Basu, N, et al.
Publicado: (2014)

The characterisation and determinants of quality of life in ANCA associated vasculitis
por: Basu, N, et al.
Publicado: (2014)